Which supplement has proven efficacy for improving sperm motility?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Coenzyme Q10 (CoQ10) and Carnitine Have the Strongest Evidence for Improving Sperm Motility

Based on the highest quality evidence, CoQ10 and carnitine are the supplements with proven efficacy for sperm motility improvement, with carnitine showing the most robust effect specifically for motility enhancement.

Primary Recommendation

The 2022 network meta-analysis 1 provides the most comprehensive comparative evidence, analyzing 18 RCTs with 1,790 subfertile men. This study directly compared 8 different antioxidants and found:

  • Carnitine demonstrated the highest efficacy for sperm motility (MD = 12.43; 95% CI: 4.07,20.26; SUCRA: 88.7%) - this was statistically significant compared to placebo
  • CoQ10 also significantly improved sperm motility (MD = 7.33; 95% CI: 0.35,14.17) and ranked highest for sperm concentration (SUCRA: 79.4%)

Supporting Evidence and Nuances

The 2025 multivitamin supplement study 2 corroborates these findings, showing significant improvements in sperm motility (p=0.014 for elite players, p=0.02 for amateur players) with supplements containing antioxidants supporting the one-carbon metabolic cycle.

Other Supplements with Evidence:

Selenium showed promise in older studies 3, with significant improvement in sperm motility (p=0.023) and 11% achieving paternity versus 0% in placebo. However, only 56% of patients responded to treatment, indicating variable efficacy.

Vitamin C demonstrated improvements in a small 2006 study 4 (mean motility increased from 31.2% to 60.1%, p<0.001), but this was a small open-label trial with only 13 patients.

Resveratrol-based supplements 5 showed improvements in motility (48.3% to 59.0%, p=0.0001) after 3-6 months, though this was a single-center pilot study.

Critical Caveat

The most recent 2025 systematic review 6 found no convincing evidence for pregnancy or live birth outcomes with any dietary supplements, despite improvements in individual sperm parameters. The certainty of evidence was rated as low or very low for most interventions. This highlights a crucial disconnect: improving sperm motility on paper does not necessarily translate to improved fertility outcomes.

Clinical Application Algorithm

  1. First-line choice: Carnitine (for motility-specific improvement) or CoQ10 (for both concentration and motility)
  2. Treatment duration: Minimum 3 months (spermatogenesis cycle is approximately 74 days)
  3. Monitoring: Repeat semen analysis after 3 months, remembering that semen parameters are highly variable 7
  4. Realistic expectations: Counsel patients that while these supplements may improve laboratory parameters, evidence for actual pregnancy outcomes remains limited 6

Important Pitfalls

  • Avoid relying on point-of-care or mail-in semen tests - these lack the accuracy of specialized andrology laboratory testing 7
  • Do not assume all patients will respond - selenium studies showed only 56% response rate 3
  • Combination supplements are not necessarily superior - the network meta-analysis found single agents (carnitine, CoQ10) performed better than multi-ingredient formulations 1
  • Laboratory improvement ≠ fertility improvement - the disconnect between sperm parameter improvement and actual pregnancy rates must be clearly communicated to patients 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.